JPH0651682B2 - Method for producing uracil derivative - Google Patents
Method for producing uracil derivativeInfo
- Publication number
- JPH0651682B2 JPH0651682B2 JP20922286A JP20922286A JPH0651682B2 JP H0651682 B2 JPH0651682 B2 JP H0651682B2 JP 20922286 A JP20922286 A JP 20922286A JP 20922286 A JP20922286 A JP 20922286A JP H0651682 B2 JPH0651682 B2 JP H0651682B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- formula
- carbon atoms
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Description
【発明の詳細な説明】 産業上の利用分野 本発明はウラシル誘導体の製造方法、より詳細にはシア
ノエチルアミン誘導体を出発原料とするウラシル誘導体
の製造方法の改良に関する。TECHNICAL FIELD The present invention relates to a method for producing a uracil derivative, and more particularly to an improvement in a method for producing a uracil derivative starting from a cyanoethylamine derivative.
従来の技術 ウラシル誘導体のなかには、制ガン作用、抗ウイルス作
用、抗菌作用または殺虫作用等の生理活性を有する化合
物が多く含まれており、また、このような生理活性を有
する化合物の中間体としても重要なものが多いだけでな
く、紫外線による光二量化物は集積回路等のレジスト材
料として近年注目を浴びつつある。2. Description of the Related Art Uracil derivatives include many compounds having physiological activity such as anticancer activity, antiviral activity, antibacterial activity or insecticidal activity, and also as intermediates of compounds having such physiological activity. Not only are there many important ones, but photodimers by ultraviolet rays have been attracting attention in recent years as resist materials for integrated circuits and the like.
ウラシル誘導体の製造法としてシアノエチルアミン誘導
体を出発原料とする方法、例えばシアノエチルアミン誘
導体とイソシアン酸のアルカリ金属塩を塩酸水溶液中で
反応させる方法が知られている。As a method for producing a uracil derivative, a method using a cyanoethylamine derivative as a starting material, for example, a method of reacting a cyanoethylamine derivative with an alkali metal salt of isocyanic acid in an aqueous hydrochloric acid solution is known.
発明が解決しようとする問題点 しかしながら、この製造法の場合には、イソシアン酸塩
が塩酸水溶液中で不安定なイソシアン酸水素となって速
やかに分解するために、比較的結晶性が高くて水に難溶
性のシアノエチルアミン誘導体との反応が困難となり、
収率が非常に低くなるという欠点がある。DISCLOSURE OF THE INVENTION Problems to be Solved by the Invention However, in the case of this production method, since the isocyanate salt is rapidly decomposed into unstable hydrogen isocyanate in an aqueous solution of hydrochloric acid, it has relatively high crystallinity and water. It becomes difficult to react with the cyanoethylamine derivative, which is sparingly soluble in
The disadvantage is that the yield is very low.
本発明は、シアノエチルアミン誘導体を出発原料として
ウラシル誘導体を製造する従来法のこのような欠点を改
良するためになされたものである。The present invention has been made to overcome such drawbacks of the conventional method for producing a uracil derivative from a cyanoethylamine derivative as a starting material.
問題点を解決するための手段 本発明は一般式[I]: (式中、R1は水素原子、炭素原子数1〜5のアルキ
ル、アリールまたはビニル基、R2は水素原子、炭素原
子数1〜5のアルキルまたはアリール基、Yは酸素原
子、硫黄原子またはイミノ基を表わす)で表わされる化
合物をりん酸の存在下、加熱環化することを特徴とす
る、 一般式[II]: (式中、R1、R2およびYは前記と同意義) で表わされるウラシル誘導体の製造方法に関する。Means for Solving the Problems The present invention has the general formula [I]: (Wherein R 1 is a hydrogen atom, an alkyl, aryl or vinyl group having 1 to 5 carbon atoms, R 2 is a hydrogen atom, an alkyl or aryl group having 1 to 5 carbon atoms, Y is an oxygen atom, a sulfur atom or A compound represented by (imino group) is subjected to thermal cyclization in the presence of phosphoric acid, represented by the general formula [II]: (Wherein R 1 , R 2 and Y have the same meaning as defined above).
一般式[I]で表わされる化合物は、以下のごとき方法
で製造することができる。The compound represented by the general formula [I] can be produced by the following method.
即ち、R2が水素である化合物[I]は、一般式[II
I] NC−CH2CH2−NH−R1 [III] (式中、R1は水素原子、炭素原子数1〜5のアルキル
基、アリール基またはビニル基を示す) で表わされるシアノエチルアミン誘導体と一般式[I
V]: (式中、Yは酸素原子、イオウ原子またはイミノ基を示
す) で表わされる尿素化合物とを鉱酸水溶液中で反応させる
ことにより得られる。本発明者らは上記反応において鉱
酸としてりん酸を用いると化合物[I]の収率が著しく
向上することを見出した。That is, the compound [I] in which R 2 is hydrogen has the general formula [II
(Wherein, R 1 represents a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, an aryl group or a vinyl group) I] NC-CH 2 CH 2 -NH-R 1 [III] cyanoethyl amine derivative represented by the And the general formula [I
V]: (In the formula, Y represents an oxygen atom, a sulfur atom or an imino group) and a urea compound represented by the formula: The present inventors have found that the use of phosphoric acid as a mineral acid in the above reaction significantly improves the yield of compound [I].
りん酸を使用する場合、りん酸は70重量%以上の水溶
液として用いるのが適当である。When phosphoric acid is used, it is appropriate to use phosphoric acid as an aqueous solution of 70% by weight or more.
リン酸としては通常、正リン酸または無水リン酸を使用
するが、ポリリン酸、メタリン酸およびピロリン酸等の
重合リン酸を使用してもよい。Orthophosphoric acid or phosphoric anhydride is usually used as phosphoric acid, but polymerized phosphoric acid such as polyphosphoric acid, metaphosphoric acid and pyrophosphoric acid may be used.
リン酸の使用量はシアノエチルアミン誘導体に対して通
常1当量以上、好ましくは2〜10当量である。The amount of phosphoric acid used is usually 1 equivalent or more, preferably 2 to 10 equivalents, relative to the cyanoethylamine derivative.
反応温度は20〜110℃が適当であり、それ以上の温
度で反応すると後述するごとく、生成した化合物[I]
の環化が同時に進行し、ウラシル誘導体[II]が得られ
る。A suitable reaction temperature is 20 to 110 ° C., and when the reaction is carried out at a temperature higher than that, the compound [I] produced is formed as described later.
And the uracil derivative [II] is obtained.
上記反応で得られる化合物[I]は、冷却して水を加え
ると結晶として単離できる。The compound [I] obtained by the above reaction can be isolated as crystals by cooling and adding water.
本発明ウラシル誘導体[II]は上記化合物[I]を単離
後りん酸の存在下に加熱(110〜200℃、好ましく
は120〜170℃)すると環化して得られる。しかし
ながら、本発明ウラシル誘導体[II]は上記化合物
[I]を単離することなく、シアノエチルアミン誘導体
[III]と尿素化合物[IV]の一段反応によっても得る
ことができる。この場合、ウラシル誘導体[II]は化合
物[I]を経由して合成されるものと考えられる。りん
酸濃度は前述の通りであり、反応温度も当初低温(好ま
しくは20〜110℃)で、次いで110〜200℃に
昇温して行なってもよい。The uracil derivative [II] of the present invention is obtained by isolating the above compound [I] and then cyclizing it by heating (110 to 200 ° C, preferably 120 to 170 ° C) in the presence of phosphoric acid. However, the uracil derivative [II] of the present invention can also be obtained by a one-step reaction of the cyanoethylamine derivative [III] and the urea compound [IV] without isolation of the compound [I]. In this case, the uracil derivative [II] is considered to be synthesized via the compound [I]. The phosphoric acid concentration is as described above, and the reaction temperature may be initially low (preferably 20 to 110 ° C.) and then elevated to 110 to 200 ° C.
化合物[I]においてR2が水素以外の基の場合、例え
ば炭素数1〜5のアルキル基やアリール基の場合は尿素
化合物[IV]に代えて相当するイソシアン酸エステル
[V]を使用すればよい。反応条件は尿素化合物を用い
る場合と同様である。When R 2 in the compound [I] is a group other than hydrogen, for example, when it is an alkyl group or an aryl group having 1 to 5 carbon atoms, the corresponding isocyanate compound [V] is used instead of the urea compound [IV]. Good. The reaction conditions are the same as when using a urea compound.
本発明において使用する一般式[III]で表わされるシ
アノエチルアミン誘導体は例えばアクリロニトリルとア
ミン類を反応させることによって調製することができ、
特にシアノエチルアミノベンゼン誘導体が好ましい。The cyanoethylamine derivative represented by the general formula [III] used in the present invention can be prepared, for example, by reacting acrylonitrile with amines,
Particularly preferred is a cyanoethylaminobenzene derivative.
一般式[III]において、R1は水素原子、炭素原子数
1〜5のアルキル基、例えばメチル基、エチル基、n−
プロピル基、イソプロピル基、n−ブチル基、n−ペン
チル基等、アリール基またはビニル基を示す。アリール
基としてはフェニル基、ナフチル基等であって、置換
基、例えばメチル、エチル等の低級アルキル基、ハロゲ
ン原子、カルボキシル基、アルコキシカルボニル基、ニ
トロ基、スルホン基等を有してもよい。ビニル基として
はビニル基、アリル基、1−プロペニル基、イソプロペ
ニル基等が例示される。In the general formula [III], R 1 is a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, for example, a methyl group, an ethyl group, n-
A propyl group, an isopropyl group, an n-butyl group, an n-pentyl group, an aryl group or a vinyl group is shown. The aryl group is a phenyl group, a naphthyl group or the like, and may have a substituent, for example, a lower alkyl group such as methyl or ethyl, a halogen atom, a carboxyl group, an alkoxycarbonyl group, a nitro group or a sulfone group. Examples of the vinyl group include a vinyl group, an allyl group, a 1-propenyl group and an isopropenyl group.
本発明に用いられる尿素化合物[IV]の具体例として
は、尿素、チオ尿素、グアニジン等が例示される。Specific examples of the urea compound [IV] used in the present invention include urea, thiourea and guanidine.
一般式[V]で表わされるイソシアン酸エステルとして
はイソシアン酸のメチルエステル、エチルエステル、イ
ソプロピルエステル、n−プロピルエステル、n−ブチ
ルエステル、t−ブチルエステルまたはフェニルエステ
ル等が例示される。Examples of the isocyanic acid ester represented by the general formula [V] include methyl ester, ethyl ester, isopropyl ester, n-propyl ester, n-butyl ester, t-butyl ester or phenyl ester of isocyanic acid.
以下、本発明を実施例によって説明する。Hereinafter, the present invention will be described with reference to examples.
実施例1 N−2−シアノエチルアニリン10g(68.5mmol)
および尿素10g(167mmol)を85%リン酸水溶液
50mに加えた反応液を攪拌下、110℃で5時間反
応させ、反応混合物を160℃で5時間減圧処理に付し
た後、冷却し、生成した赤色固体に水400mを加
え、析出した白色沈澱物を濾取し、エタノールから再結
晶させることによって1−フェニルジヒドロウラシル
3.3gを得た(m.p.:194〜196℃、IRスペク
トルおよび1H−NMRをそれぞれ第1図および第2図
に示す)。Example 1 10 g (68.5 mmol) of N-2-cyanoethylaniline
And 10 g (167 mmol) of urea added to 50 m of 85% phosphoric acid aqueous solution were reacted with stirring at 110 ° C. for 5 hours, and the reaction mixture was subjected to a reduced pressure treatment at 160 ° C. for 5 hours and then cooled to form. 400 m of water was added to the red solid, and the white precipitate thus deposited was collected by filtration and recrystallized from ethanol to obtain 3.3 g of 1-phenyldihydrouracil (mp: 194 to 196 ° C., IR spectrum and 1 H- NMR is shown in FIG. 1 and FIG. 2, respectively.
実施例2 N−2−シアノエチルアニリン2.0g(14mmol)に
嫌気条件下にイソシアン酸フェニル1.83m(17
mmol)およびトリエチルアミン0.5mを加えた反応
液を室温で4時間攪拌した後、85%リン酸水溶液10
mを加え、攪拌下、130℃で6時間反応させ、冷却
後、反応混合物に水50mを加え、析出した沈澱物を
濾取し、エタノールから再結晶させることによって、
1,3−ジフェニルジヒドロウラシル1.0gを得た
(m.p.:229〜230℃、IRスペクトルおよび1H
−NMRをそれぞれ第3図および第4図に示す)。Example 2 2.0 g (14 mmol) of N-2-cyanoethylaniline under anaerobic conditions 1.83 m (17) of phenyl isocyanate
mmol) and 0.5 ml of triethylamine were stirred at room temperature for 4 hours, and then 85% phosphoric acid aqueous solution 10
m, and the mixture was reacted at 130 ° C. for 6 hours under stirring. After cooling, 50 m of water was added to the reaction mixture, and the deposited precipitate was collected by filtration and recrystallized from ethanol.
1.0 g of 1,3-diphenyldihydrouracil was obtained (mp: 229-230 ° C., IR spectrum and 1 H
-NMR is shown in Figures 3 and 4 respectively).
実施例3 N−2−シアノエチルアニリン35g(0.24mol)
に嫌気条件下にイソシアン酸イソプロピル28.9g
(0.34mol)およびトリエチルアミン12.4m
を加えた反応液を室温で2時間攪拌しN−イソプロピル
−N′−(2−シアノエチル)−N′−フェニル尿素を
得た。(m.p.:76〜77℃、IRおよび1H−NMR
をそれぞれ第5図および第6図に示す)。Example 3 35 g (0.24 mol) of N-2-cyanoethylaniline
28.9 g of isopropyl isocyanate under anaerobic conditions
(0.34 mol) and triethylamine 12.4 m
The reaction solution to which was added was stirred at room temperature for 2 hours to obtain N-isopropyl-N '-(2-cyanoethyl) -N'-phenylurea. (Mp: 76-77 ° C, IR and 1 H-NMR
Are shown in FIG. 5 and FIG. 6, respectively).
次いで85%リン酸水溶液200mを加え、攪拌下、
130℃で6時間反応させることによって1−フェニル
−3−イソプロピルジヒドロウラシを得た。Next, 200m of 85% phosphoric acid aqueous solution was added, and with stirring.
By reacting at 130 ° C. for 6 hours, 1-phenyl-3-isopropyldihydrouracil was obtained.
発明の効果 本発明方法により、医薬や農薬等として有用なウラシル
誘導体およびこれらの化合物の中間体として有用なウラ
シル誘導体を比較的温和な条件下で収率よく簡便に製造
することができる。EFFECTS OF THE INVENTION According to the method of the present invention, a uracil derivative useful as a medicine, a pesticide or the like and a uracil derivative useful as an intermediate of these compounds can be easily produced in good yield under relatively mild conditions.
第1図および第2図は1−フェニルジヒドロウラシルの
IRおよび1H−NMRのチャート、第3図および第4
図は1,3−ジフェニルヒドロウラシルのIRおよび1
H−NMRのチャートおよび第5図および第6図はN−
イソプロピル−N′−(2−シアノエチル)−N′−フ
ェニル尿素のIRおよび1H−NMRのチャートをそれ
ぞれ示す。1 and 2 are IR and 1 H-NMR charts of 1 -phenyldihydrouracil, FIGS. 3 and 4
The figure shows the IR and 1 of 1,3-diphenylhydrouracil
H-NMR chart and FIGS. 5 and 6 are N-
The IR and 1 H-NMR charts of isopropyl-N ′-(2-cyanoethyl) -N′-phenylurea are shown, respectively.
Claims (9)
ル、アリールまたはビニル基、R2は水素原子、炭素原
子数1〜5のアルキルまたはアリール基、Yは酸素原
子、硫黄原子またはイミノ基を表わす)で表わされる化
合物をりん酸の存在下、加熱環化することを特徴とす
る、一般式[II]: (式中、R1、R2およびYは前記と同意義)で表わさ
れるウラシル誘導体の製造法。1. A general formula [I]: (Wherein R 1 is a hydrogen atom, an alkyl, aryl or vinyl group having 1 to 5 carbon atoms, R 2 is a hydrogen atom, an alkyl or aryl group having 1 to 5 carbon atoms, Y is an oxygen atom, a sulfur atom or A compound represented by the general formula [II]: wherein the compound represented by imino group is heated and cyclized in the presence of phosphoric acid. (In the formula, R 1 , R 2 and Y have the same meanings as described above).
法。2. The method according to claim 1, wherein R 1 is an aryl group.
載の製造法。5. The production method according to claim 1, wherein heating is performed at 120 to 170 ° C.
基、アリール基またはビニル基を示す)で表わされるシ
アノエチルアミン誘導体、および 一般式[IV]: (式中、Yは酸素原子、イオウ原子またはイミノ基を示
す) で表わされる尿素化合物または 一般式[V]: O=C=N−R3 [V] (式中、R3は炭素原子数1〜5のアルキル基またはア
リール基を示す) で表わされるイソシアン酸エステルをリン酸の存在下に
反応させることを特徴とする、 一般式[II]: (式中、R1およびYは前記と同意義であり、R2は水
素原子、炭素原子数1〜5のアルキル基またはアリール
基を示す) で表わされるウラシル誘導体の製造法。6. General formula [III]: NC—CH 2 CH 2 —NH—R 1 [III] (In the formula, R 1 is a hydrogen atom, an alkyl group having 1 to 5 carbon atoms, an aryl group or a vinyl group. And a cyanoethylamine derivative represented by the general formula [IV]: (In the formula, Y represents an oxygen atom, a sulfur atom or an imino group) or a general formula [V]: O = C = NR 3 [V] (In the formula, R 3 is the number of carbon atoms. 1 to 5 representing an alkyl group or an aryl group) is reacted in the presence of phosphoric acid in the general formula [II]: (In the formula, R 1 and Y have the same meanings as described above, and R 2 represents a hydrogen atom, an alkyl group or an aryl group having 1 to 5 carbon atoms).
法。7. The method according to claim 6, wherein R 1 is an aryl group.
化合物[IV]またはイソシアン酸エステル[V]の反応
を予め20〜110℃で行ない、次いで110〜200
℃で反応させる第6項記載の製造法。9. A reaction between a cyanoethylamine derivative [III] and a urea compound [IV] or an isocyanate ester [V] is previously carried out at 20 to 110 ° C., and then 110 to 200.
The method according to item 6, wherein the reaction is carried out at a temperature of ℃
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20922286A JPH0651682B2 (en) | 1986-09-05 | 1986-09-05 | Method for producing uracil derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20922286A JPH0651682B2 (en) | 1986-09-05 | 1986-09-05 | Method for producing uracil derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6366173A JPS6366173A (en) | 1988-03-24 |
JPH0651682B2 true JPH0651682B2 (en) | 1994-07-06 |
Family
ID=16569371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP20922286A Expired - Lifetime JPH0651682B2 (en) | 1986-09-05 | 1986-09-05 | Method for producing uracil derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0651682B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0885197A1 (en) * | 1996-03-07 | 1998-12-23 | American Home Products Corporation | 2-thioxotetrahydropyrimidin-4-one derivatives |
-
1986
- 1986-09-05 JP JP20922286A patent/JPH0651682B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPS6366173A (en) | 1988-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2434855C2 (en) | Novel imidazole derivatives, their obtaining and application as medications | |
US6008363A (en) | Process for producing guanidine derivatives, intermediates therefor and their production | |
US4259344A (en) | Sulfur-containing benzimidazole derivatives | |
DE2849537A1 (en) | Hypotensive imidazolinyl:amino-pyrimidine derivs. - prepd. e.g. by reacting n-pyrimidinyl-s-alkyl-isothiouronium salts with ethylene-di:amine | |
JPH0560457B2 (en) | ||
EP0068407A1 (en) | Aminosulfonylbenzoic acid derivatives | |
EP0453731A2 (en) | Improved process for the synthesis of N-3-(1H-imidazol-1-yl)phenyl-4-(substituted)-2-pyrimidinamines | |
JPH0651682B2 (en) | Method for producing uracil derivative | |
US5030738A (en) | Synthesis of antiulcer compounds | |
JPH0641135A (en) | Imidazopteridine derivative and its production | |
US4985563A (en) | Process for the preparation of 6-piperidino-2,4-diamino pyrimidine-3-oxide | |
US3461131A (en) | Process for preparing 2-substituted cycloheptimidazole derivatives | |
JPS60208963A (en) | Manufacture of diaminopyridine derivative | |
JPH0558985A (en) | Production of cyanoguanidine derivative | |
JPS63239273A (en) | Phenylimidazole derivative | |
WO1999044996A1 (en) | Process for preparing 3- hydroxy- 5-[(1, 4,5,6- tetrahydro-5-hydroxy- 2- pyrimidinyl)amino]benzoic acid | |
EP0435995A1 (en) | New quinoline derivatives and process for the preparation thereof | |
JPH06102656B2 (en) | Ranitidine manufacturing method | |
KR890002250B1 (en) | Process for preparing triazine derivatives | |
SU1671660A1 (en) | Method for preparation of 2-selenooxo-5- arylideneimidazolidine-4-ones | |
JPH0212231B2 (en) | ||
AT266115B (en) | Process for the preparation of new aliphatic α- (3-indolyl) -carboxylic acids and their salts | |
JPS634538B2 (en) | ||
JPH0770090A (en) | Production of irsogladine and its acid addition salt | |
US5110945A (en) | 1-azoniabicyclo[3.3.0]oct-1(5)-ene salt derivatives and process for the preparation of the same |